Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 2/2015

01.02.2015 | Original Article

Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague–Dawley rats

verfasst von: Kuppusamy Periyasamy, Kuppusamy Baskaran, Aruldass Ilakkia, Kalappan Vanitha, Sundaramoorthy Selvaraj, Dhanapal Sakthisekaran

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the present study was to assess the chemopreventive and chemotherapeutic efficacy of tangeretin on DMBA-induced oxidative stress in breast cancer-bearing Sprague–Dawley rats.

Methods

In this study, the experimental animals were divided into five groups of six animals each. Group I was control, Group II was DMBA-induced breast cancer-bearing rats, Group III was tangeretin pre-treated (50 mg/kg body weight for 30 days orally) breast cancer-bearing animals, Group IV was tangeretin post-treated (50 mg/kg body weight for 30 days orally) and Group V was tangeretin (50 mg/kg body weight) alone treated animals.

Results

We have observed the general characteristics of cancer, oxidative stress markers, breast cancer marker, antioxidants and histopathological changes in the experimental animals. We have recorded the body weight, tumor weights, tumor volume and antitumor activity of tangeretin in the experimental animals. Oxidative stress markers, like NO and LPO, and breast cancer marker CEA levels were significantly (p < 0.001, p < 0.05) increased as well as the antioxidants like SOD, CAT, GPx, GST, GSH, ascorbic acid and α-tocopherol were found to be significantly (p < 0.05) decreased in cancer-bearing Group II animals. Whereas, the enzymic and non-enzymic antioxidant levels were found to be significantly decreased in cancer-bearing animals. However, in tangeretin pre-treated and post- treated animals, the levels of antioxidants and breast cancer marker were found to be significantly (p < 0.05) reduced with a concomitant increase in the activities of the antioxidants (p < 0.05). In tangeretin alone treated Group V animals, no significant changes were observed in the levels of antioxidants and breast cancer marker. These results were adequately supported by the histopathological studies in the mammary tissues of the experimental animals.

Conclusion

From this study, we conclude that the administration of tangeretin was found to be beneficial against DMBA-induced oxidative stress in breast cancer-bearing animals. Hence, we strongly suggest that tangeretin is effective and efficient candidate for the treatment of experimental breast cancer.
Literatur
1.
Zurück zum Zitat Kosenko E, Kaminsky Y, Lopata O, Muravyov N, Kaminsky A, Hermenegildo C, Stavroskaya IG, Felipo V (1998) Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab Brain Dis 13:29–41PubMedCrossRef Kosenko E, Kaminsky Y, Lopata O, Muravyov N, Kaminsky A, Hermenegildo C, Stavroskaya IG, Felipo V (1998) Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab Brain Dis 13:29–41PubMedCrossRef
2.
Zurück zum Zitat Schliess F, Gorg B, Fischer R, Desjardins P, Bidmon HJ, Herrmann A, Butterworth RF, Zilles K, Haussinger D (2002) Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine and residues in rat astrocytes. FASEB J 16:739–741PubMed Schliess F, Gorg B, Fischer R, Desjardins P, Bidmon HJ, Herrmann A, Butterworth RF, Zilles K, Haussinger D (2002) Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine and residues in rat astrocytes. FASEB J 16:739–741PubMed
3.
Zurück zum Zitat Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65:899–911CrossRef Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65:899–911CrossRef
4.
Zurück zum Zitat Ioannides C (2002) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York Ioannides C (2002) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York
5.
Zurück zum Zitat Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34:369–376PubMedCrossRef Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34:369–376PubMedCrossRef
6.
Zurück zum Zitat Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168–174PubMedCrossRef Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168–174PubMedCrossRef
7.
Zurück zum Zitat Ekambaram G, Rajendran P, Magesh V, Sakthisekaran D (2008) Naringenin reduces tumor size and weight lost in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 28(2):106–112PubMedCrossRef Ekambaram G, Rajendran P, Magesh V, Sakthisekaran D (2008) Naringenin reduces tumor size and weight lost in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 28(2):106–112PubMedCrossRef
8.
Zurück zum Zitat Mukhtar H, Ahmad N (1999) Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol 158(3):207–210PubMedCrossRef Mukhtar H, Ahmad N (1999) Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol 158(3):207–210PubMedCrossRef
9.
Zurück zum Zitat Krishnan K, Ruffin MT IV, Brenner DE (1998) Cancer chemoprevention. A new way to treat cancer before it happens. Prim Care 25(2):361–379PubMedCrossRef Krishnan K, Ruffin MT IV, Brenner DE (1998) Cancer chemoprevention. A new way to treat cancer before it happens. Prim Care 25(2):361–379PubMedCrossRef
10.
Zurück zum Zitat Ding M, Yongju L, Bowman L, Huang C, Leonard S, Wang L, Vallyathan V, Castranova V, Shi X (2004) Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J Biol Chem 279:10670–10676PubMedCrossRef Ding M, Yongju L, Bowman L, Huang C, Leonard S, Wang L, Vallyathan V, Castranova V, Shi X (2004) Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J Biol Chem 279:10670–10676PubMedCrossRef
11.
Zurück zum Zitat Nelson EK (1934) The occurrence of a pentamethyl flavonol in tangerine peel. J Am Chem Soc 56:1392–1393CrossRef Nelson EK (1934) The occurrence of a pentamethyl flavonol in tangerine peel. J Am Chem Soc 56:1392–1393CrossRef
12.
Zurück zum Zitat Pan Min-Hsiung, Chen Wei-Jen, Lin-Shiau Shoei-Yn, Ho Chi-Tang, Lin Jen-Kun (2002) Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23(10):1677–1684PubMedCrossRef Pan Min-Hsiung, Chen Wei-Jen, Lin-Shiau Shoei-Yn, Ho Chi-Tang, Lin Jen-Kun (2002) Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23(10):1677–1684PubMedCrossRef
13.
Zurück zum Zitat Yao X, Xu X, Fan G, Qiao Y, Cao S, Pan S (2009) Determination of synergistic effects of polymethoxylated flavones extracts of Jinchen orange peels (Citrus Sinensis Osberk) with amino acids and organic acids using chemiluminescence. Eur Food Res Technol 229:743–750CrossRef Yao X, Xu X, Fan G, Qiao Y, Cao S, Pan S (2009) Determination of synergistic effects of polymethoxylated flavones extracts of Jinchen orange peels (Citrus Sinensis Osberk) with amino acids and organic acids using chemiluminescence. Eur Food Res Technol 229:743–750CrossRef
14.
Zurück zum Zitat Lowry O, Rosebrough N, Farr A, Fassino G, Vertua R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry O, Rosebrough N, Farr A, Fassino G, Vertua R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
15.
Zurück zum Zitat Polat A, Parlakpinar H, Tasdemir S, Colak C, Vardi N, Ucar M, Emre MH, Acet A (2006) Protective role of aminoguanidine on gentamicin-induced acute renal failure in rats. Acta Histochem 108:365–371PubMedCrossRef Polat A, Parlakpinar H, Tasdemir S, Colak C, Vardi N, Ucar M, Emre MH, Acet A (2006) Protective role of aminoguanidine on gentamicin-induced acute renal failure in rats. Acta Histochem 108:365–371PubMedCrossRef
16.
Zurück zum Zitat Devasagayam TP, Tarachand U (1987) Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 145(1):134–138PubMedCrossRef Devasagayam TP, Tarachand U (1987) Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 145(1):134–138PubMedCrossRef
17.
Zurück zum Zitat Marklund S, Marlund G (1974) Involvement of superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRef Marklund S, Marlund G (1974) Involvement of superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRef
18.
Zurück zum Zitat Johansson LH, Borg LAH (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331–336PubMedCrossRef Johansson LH, Borg LAH (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331–336PubMedCrossRef
19.
Zurück zum Zitat Rotruck JT, Pop AL, Ganther H, Hafeman BG, Hoeksira WG (1973) Selenium: biochemical role as a component of glutathione peroxides. Science 179:588–590PubMedCrossRef Rotruck JT, Pop AL, Ganther H, Hafeman BG, Hoeksira WG (1973) Selenium: biochemical role as a component of glutathione peroxides. Science 179:588–590PubMedCrossRef
20.
Zurück zum Zitat Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7136PubMed Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7136PubMed
21.
Zurück zum Zitat Moron MS, DePierre JW, Manerwik KB (1979) Levels of glutathione, glutathione reductase and glutathione-S-transferase acitivities in rat lung and liver. Biochim Biophys Act 582:67–68CrossRef Moron MS, DePierre JW, Manerwik KB (1979) Levels of glutathione, glutathione reductase and glutathione-S-transferase acitivities in rat lung and liver. Biochim Biophys Act 582:67–68CrossRef
22.
Zurück zum Zitat Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62:3–11PubMedCrossRef Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62:3–11PubMedCrossRef
23.
Zurück zum Zitat Gupta S, Kumar H, Soni J (2005) Effect of Vitamin E and selenium supplementation on concentrations of plasma cortisol and erythrocyte lipid peroxides and the incidence of retained fetal membranes in crossbred dairy cattle. Theriogenology 64(6):1273–1286PubMedCrossRef Gupta S, Kumar H, Soni J (2005) Effect of Vitamin E and selenium supplementation on concentrations of plasma cortisol and erythrocyte lipid peroxides and the incidence of retained fetal membranes in crossbred dairy cattle. Theriogenology 64(6):1273–1286PubMedCrossRef
24.
Zurück zum Zitat Davis L, Kuttan G (2001) Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol 75(2–3):165–168PubMedCrossRef Davis L, Kuttan G (2001) Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol 75(2–3):165–168PubMedCrossRef
25.
Zurück zum Zitat Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Curr Med Chem 11(9):1163–1182PubMedCrossRef Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Curr Med Chem 11(9):1163–1182PubMedCrossRef
26.
Zurück zum Zitat Choudhury R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans C (1999) Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. BiochemBiophys Res Co 265:410–415CrossRef Choudhury R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans C (1999) Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. BiochemBiophys Res Co 265:410–415CrossRef
27.
Zurück zum Zitat Cao Hui, Chen Longsheng, Xiao Jianbo (2011) Binding Citrus flavanones to human serum albumin: effect of structure on affinity. Mol Biol Rep 38:2257–2262PubMedCrossRef Cao Hui, Chen Longsheng, Xiao Jianbo (2011) Binding Citrus flavanones to human serum albumin: effect of structure on affinity. Mol Biol Rep 38:2257–2262PubMedCrossRef
28.
Zurück zum Zitat Druckrey H, Preussmann R, Ivankovic S, Schmähl D (1967) Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats. Z Krebsforsch 69(2):103–201PubMedCrossRef Druckrey H, Preussmann R, Ivankovic S, Schmähl D (1967) Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats. Z Krebsforsch 69(2):103–201PubMedCrossRef
29.
Zurück zum Zitat Levine JJ, Pettei MJ, Valderrama E, Gold DM, Kessler BH, Trachtman H (1998) Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J Pediatr Gastroenterol Nutr 26(1):34–38PubMedCrossRef Levine JJ, Pettei MJ, Valderrama E, Gold DM, Kessler BH, Trachtman H (1998) Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J Pediatr Gastroenterol Nutr 26(1):34–38PubMedCrossRef
30.
Zurück zum Zitat Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58(2):334–341PubMed Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58(2):334–341PubMed
31.
Zurück zum Zitat Lake BG, Beamand JA, Tredger JM, Barton PT, Renwick AB, Price RJ (1999) Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. Mutat Res 440:91–100PubMedCrossRef Lake BG, Beamand JA, Tredger JM, Barton PT, Renwick AB, Price RJ (1999) Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. Mutat Res 440:91–100PubMedCrossRef
32.
Zurück zum Zitat Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40PubMedCrossRef Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40PubMedCrossRef
33.
Zurück zum Zitat Bhat S, Rao G, Murthy KD, Bhat PG (2008) Seasonal variations in markers of stress and oxidative stress in rats. Indian J Clin Biochem 23:191–194PubMedCentralPubMedCrossRef Bhat S, Rao G, Murthy KD, Bhat PG (2008) Seasonal variations in markers of stress and oxidative stress in rats. Indian J Clin Biochem 23:191–194PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Meiyanto E, Hermawan A, Junedi S, Fitriasari A, Susidarti RA (2011) Nobiletin Increased Cytotoxic Activity of Doxorubicin on MCF-7 Cells But Not on T47D Cells. Int J Phytomedicine 3:129–137 Meiyanto E, Hermawan A, Junedi S, Fitriasari A, Susidarti RA (2011) Nobiletin Increased Cytotoxic Activity of Doxorubicin on MCF-7 Cells But Not on T47D Cells. Int J Phytomedicine 3:129–137
35.
Zurück zum Zitat Wang DY, Dulbrook RD, Hayward JL, Hendrick JC, Franchimont P (1975) Relationship between plasma CEA and prognosis in women with breast cancer. Eur J Cancer 11:615–625PubMedCrossRef Wang DY, Dulbrook RD, Hayward JL, Hendrick JC, Franchimont P (1975) Relationship between plasma CEA and prognosis in women with breast cancer. Eur J Cancer 11:615–625PubMedCrossRef
36.
Zurück zum Zitat Mughal AW, Hortobagyi GN, Fritsche HA, Buzdar AU, Yap HY, Blumenschein GR (1983) Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 249(14):1881–1886PubMedCrossRef Mughal AW, Hortobagyi GN, Fritsche HA, Buzdar AU, Yap HY, Blumenschein GR (1983) Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 249(14):1881–1886PubMedCrossRef
37.
Zurück zum Zitat Rogers GT (1983) Carcino embryonic antigen and related glycoproteins—molecular aspects and specificity. Biochim Biophys Acta 1983(695):227–249 Rogers GT (1983) Carcino embryonic antigen and related glycoproteins—molecular aspects and specificity. Biochim Biophys Acta 1983(695):227–249
38.
Zurück zum Zitat Hirano T, Abe K, Gotoh M, Oka K (1995) Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 72(6):1380–1388PubMedCentralPubMedCrossRef Hirano T, Abe K, Gotoh M, Oka K (1995) Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 72(6):1380–1388PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Yao X, Zhu X, Pan S, Fang Y, Jiang F, Phillips GO, Xu X (2012) Antimicrobial activity of nobiletin and tangeretin against pseudomonas. Food Chem 132:1883–1890CrossRef Yao X, Zhu X, Pan S, Fang Y, Jiang F, Phillips GO, Xu X (2012) Antimicrobial activity of nobiletin and tangeretin against pseudomonas. Food Chem 132:1883–1890CrossRef
40.
Zurück zum Zitat Mates JM, Perez-Gomez C (1999) Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 32:595–603PubMedCrossRef Mates JM, Perez-Gomez C (1999) Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 32:595–603PubMedCrossRef
41.
Zurück zum Zitat Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 7(6):2521–2526CrossRef Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 7(6):2521–2526CrossRef
42.
Zurück zum Zitat Vecanova J, Hodorova I, Mihalik J, Benicky M, Kluchova D, Rybarova S (2011) Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma. Bratisl Lek Listy 112(2):67–70PubMed Vecanova J, Hodorova I, Mihalik J, Benicky M, Kluchova D, Rybarova S (2011) Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma. Bratisl Lek Listy 112(2):67–70PubMed
43.
Zurück zum Zitat Valderrama B, Ayala M, Vazquez-Duhalt R (2002) Suicide inactivation of peroxidases and the challenge of engineering more robust enzymes. Chem Biol 9:555–565PubMedCrossRef Valderrama B, Ayala M, Vazquez-Duhalt R (2002) Suicide inactivation of peroxidases and the challenge of engineering more robust enzymes. Chem Biol 9:555–565PubMedCrossRef
44.
Zurück zum Zitat Heijnen CGM, Haenen GRMM, van Acker FAA, van der Vijgh WJF, Bast A (2001) Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol Invitro 15:3–6 Heijnen CGM, Haenen GRMM, van Acker FAA, van der Vijgh WJF, Bast A (2001) Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol Invitro 15:3–6
45.
Zurück zum Zitat Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 7(3):291–295CrossRef Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 7(3):291–295CrossRef
46.
Zurück zum Zitat Nugroho PA, Sukamdi DP, Darma AP, Jenie RI, Meiyanto E (2010) Penelusuran Mekanisme Flavonoid Kulit jeruk keprok (Citrus reticulata) Sebagai Agen Kemopreventif Melalui Docking Molekul pada Protein Target CYP1A2. Farmasains 1:37–44 Nugroho PA, Sukamdi DP, Darma AP, Jenie RI, Meiyanto E (2010) Penelusuran Mekanisme Flavonoid Kulit jeruk keprok (Citrus reticulata) Sebagai Agen Kemopreventif Melalui Docking Molekul pada Protein Target CYP1A2. Farmasains 1:37–44
Metadaten
Titel
Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague–Dawley rats
verfasst von
Kuppusamy Periyasamy
Kuppusamy Baskaran
Aruldass Ilakkia
Kalappan Vanitha
Sundaramoorthy Selvaraj
Dhanapal Sakthisekaran
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 2/2015
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-014-2629-z

Weitere Artikel der Ausgabe 2/2015

Cancer Chemotherapy and Pharmacology 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.